GlaxoSmithKline (GSK) to Close U.K. Research Center - DJN
Tweet
Share
E-mailGet Alerts GSK Hot Sheet
Join SI Premium – FREE
According to a Dow Jones Newswire, GlaxoSmithKline (NYSE: GSK) is to shutter a U.K. research center following the completion of a study on pain relief, anxiety, and depression.
The loss of jobs would amount to about 380.
The loss of jobs would amount to about 380.
You May Also Be Interested In
- Tesla touts European supervised self-driving safety data ahead of EU vote
- Exclusive: U.K. stock market ’approaching irrelevance’, Webull U.K. CEO says
- Bessent warns Strait of Hormuz will be “worthless” within 2 years
Create E-mail Alert Related Categories
General NewsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
